$31.52
-1.46-4.43%
À la fermeture: -
$31.01
-0.51-1.62%
Après les heures de négociation: 4:45 PM EDT
Carter's publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
02/25/2025 | CRI | Carter's | FY | 2025 | $3.20 | $3.80 | $4.95 | $2.78B | $2.85B | $2.80B | |
02/25/2025 | CRI | Carter's | Q1 | 2025 | $0.45 | $0.55 | $0.86 | $615.00M | $625.00M | $652.96M | |
01/07/2025 | CRI | Carter's | FY | 2024 | $4.70 | $5.15 | $5.31 | $2.79B | $2.83B | $2.82B | |
10/25/2024 | CRI | Carter's | FY | 2024 | $4.70 | $5.15 | $5.04 | $2.79B | $2.83B | $2.81B | |
10/25/2024 | CRI | Carter's | Q4 | 2024 | $1.32 | $1.72 | $1.86 | $800.00M | $840.00M | $825.49M | |
07/26/2024 | CRI | Carter's | Q3 | 2024 | $1.10 | $1.35 | $1.88 | $735.00M | $755.00M | $805.92M | |
07/26/2024 | CRI | Carter's | FY | 2024 | $4.60 | $5.05 | $6.20 | $2.79B | $2.83B | $2.92B | |
04/26/2024 | CRI | Carter's | Q2 | 2024 | $0.35 | $0.45 | $0.80 | $560.00M | $570.00M | $613.01M | |
04/26/2024 | CRI | Carter's | FY | 2024 | — | — | — | $2.95B | $3.00B | $2.96B | |
02/27/2024 | CRI | Carter's | Q1 | 2024 | $0.60 | $0.70 | $1.07 | $620.00M | $645.00M | $692.48M | |
02/27/2024 | CRI | Carter's | FY | 2024 | — | — | — | $3.00B | $3.00B | $2.98B | |
10/27/2023 | CRI | Carter's | Q4 | 2023 | $2.50 | $2.72 | $2.73 | $862.00M | $877.00M | $897.85M | |
10/27/2023 | CRI | Carter's | FY | 2023 | $5.95 | $6.15 | $5.89 | $2.95B | $2.96B | $2.98B | |
07/28/2023 | CRI | Carter's | FY | 2023 | $5.95 | $6.15 | $5.92 | $2.95B | $3.00B | $3.00B | |
07/28/2023 | CRI | Carter's | Q3 | 2023 | $1.45 | $1.55 | $1.75 | $770.00M | $790.00M | $789.07M | |
04/28/2023 | CRI | Carter's | FY | 2023 | $6.15 | $6.15 | $5.90 | $3.00B | $3.00B | $3.01B | |
04/28/2023 | CRI | Carter's | Q2 | 2023 | $0.40 | $0.50 | $0.75 | $590.00M | $605.00M | $625.80M | |
02/24/2023 | CRI | Carter's | Q1 | 2023 | $0.35 | $0.55 | $1.23 | $630.00M | $650.00M | $705.68M | |
02/24/2023 | CRI | Carter's | FY | 2023 | $6.15 | $6.15 | $6.45 | $3.00B | $3.00B | $3.18B | |
10/28/2022 | CRI | Carter's | FY | 2022 | $6.05 | $6.65 | $7.18 | $3.15B | $3.19B | $3.29B | |
10/28/2022 | CRI | Carter's | Q4 | 2022 | $1.40 | $2.00 | $2.56 | $845.00M | $885.00M | $963.82M | |
07/29/2022 | CRI | Carter's | FY | 2022 | $7.10 | $7.60 | $8.23 | $3.25B | $3.30B | $3.52B | |
07/29/2022 | CRI | Carter's | Q3 | 2022 | $1.50 | $1.70 | $2.17 | $850.00M | $865.00M | $910.98M | |
04/29/2022 | CRI | Carter's | Q2 | 2022 | $1.60 | $1.80 | $1.81 | $750.00M | $775.00M | $800.88M | |
04/29/2022 | CRI | Carter's | FY | 2022 | $8.81 | $8.97 | $8.93 | $3.56B | $3.59B | $3.57B | |
02/25/2022 | CRI | Carter's | Q1 | 2022 | $1.25 | $1.35 | $1.54 | $740.00M | $750.00M | $804.11M | |
02/25/2022 | CRI | Carter's | FY | 2022 | $8.81 | $8.97 | $7.91 | $3.56B | $3.59B | $3.57B | |
10/29/2021 | CRI | Carter's | Q4 | 2021 | $2.00 | $2.00 | $2.15 | $1.02B | $1.02B | $1.01B | |
10/29/2021 | CRI | Carter's | FY | 2021 | $7.57 | $7.57 | $7.52 | $3.45B | $3.45B | $3.52B | |
07/30/2021 | CRI | Carter's | FY | 2021 | $7.28 | $7.28 | $6.34 | $3.48B | $3.48B | $3.40B | |
07/30/2021 | CRI | Carter's | Q3 | 2021 | $1.60 | $1.60 | $1.50 | $960.00M | $960.00M | $873.33M | |
04/30/2021 | CRI | Carter's | Q2 | 2021 | $0.68 | $0.68 | $0.65 | $695.10M | $695.10M | $659.75M | |
04/30/2021 | CRI | Carter's | FY | 2021 | $5.82 | $5.82 | $4.92 | $3.33B | $3.33B | $3.26B | |
02/26/2021 | CRI | Carter's | Q1 | 2021 | $0.25 | $0.25 | $0.75 | — | — | — | |
02/26/2021 | CRI | Carter's | FY | 2021 | $4.58 | $4.58 | $6.36 | $3.18B | $3.18B | $3.38B |
Les dernières prévisions pour Carter's (CRI) ont été communiquées le février 25, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $3.20 à $3.80, par rapport à un BPA estimé de $4.95. De plus, Carter's a prévu un chiffre d'affaires entre $2.78B et $2.86B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.